Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
Status:
Recruiting
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
This 12-month study will evaluate the efficacy of aripiprazole lauroxil compared to oral
aripiprazole in preventing the re-emergence of psychotic symptoms in patients with a recent
onset of schizophrenia.